RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis.

Efficacy and safety of novel dual glucokinase activator dorzagliatin in type-2 diabetes A meta-analysis.

Add to Collection
2023 Jan Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Dutta, Deep', 'Khandelwal, Deepak', 'Kumar, Manoj', 'Sharma, Meha']
Journal Title : Diabetes & metabolic syndrome
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

BACKGROUND & AIMS: Glucokinase has a critical role in regulating glucose homeostasis in humans, and has been a target for diabetes drug development since 1990s. Dorzagliatin is a novel allosteric dual glucokinase activator targeting both pancreatic and he.....

Keywords : ["novel dual glucokinase activator dorzagliatin", "safety", "metaanalysis", "efficacy", "diabetes"]